In vitro and in vivo experiments using SIRT1 inhibitors showed a reduction in tumor growth associated with enhanced ciliary expression, suggesting that the reestablishment of PCs in CCA cells by means of SIRT1 inhibitors may be a potential therapeutic approach [128]. This evidence concerns the gene SIRT1 and cholangiocarcinoma.